Sumatriptan
- TRADE NAME: Alsuma (King); Imigrane; Imitrex (GSK)
- INDICATIONS: Migraine attacks, cluster headaches
- CLASS: 5-HT1 agonist, Serotonin receptor agonist, Triptan
- HALF-LIFE: 2.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Citalopram, Dihydroergotamine, Ergot-containing drugs, Escitalopram, Fluoxetine, Fluvoxamine, Isocarboxazid, MAO inhibitors, Methysergide, Naratriptan, Nefazodone, Paroxetine, Phenelzine, Rizatriptan, Sertraline, Sibutramine, St John's Wort, Tranylcypromine, Venlafaxine, Zolmitriptan
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
OCULAR
LOCAL
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric